Aurora Cannabis Buys Anandia Laboratories in All-Stock Deal Valued at $115 Million

Aurora Cannabis Buys Anandia Laboratories in All-Stock Deal Valued at $115 Million

Anandia provides research and development services as well as analytical testing for clients licensed under Canada’s medical cannabis rules.

Subscribe
June 13, 2018
Globe and Mail
Canada Mergers and Acquisitions News

Aurora Cannabis Inc. has signed an agreement to buy Anandia Laboratories Inc. in an all-stock deal valued at $115-million.

Anandia provides research and development services as well as analytical testing for clients licensed under Canada’s medical cannabis rules.

Aurora CEO Terry Booth says the deal expands his company’s capabilities and will help accelerate product development.

Read more

Top Image: © Miravision | Adobe Stock

Canada